Free Trial

BioLargo (BLGO) Competitors

BioLargo logo
$0.21
-0.01 (-4.50%)
(As of 11/4/2024 ET)

BLGO vs. ARQ, ORGN, ALTO, VGAS, AMTX, TLGY, EVGN, CBUS, SDST, and LOOP

Should you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include ARQ (ARQ), Origin Materials (ORGN), Alto Ingredients (ALTO), Verde Clean Fuels (VGAS), Aemetis (AMTX), TLGY Acquisition (TLGY), Evogene (EVGN), Cibus (CBUS), Stardust Power (SDST), and Loop Industries (LOOP). These companies are all part of the "chemicals" industry.

BioLargo vs.

ARQ (NASDAQ:ARQ) and BioLargo (NASDAQ:BLGO) are both small-cap business services companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, risk, earnings, media sentiment, profitability, dividends, valuation and institutional ownership.

BioLargo has lower revenue, but higher earnings than ARQ. ARQ is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ARQ$99.18M2.18-$12.25M-$0.12-49.25
BioLargo$12.23M5.22-$3.50M-$0.02-10.60

ARQ has a beta of 1.4, suggesting that its share price is 40% more volatile than the S&P 500. Comparatively, BioLargo has a beta of 0.2, suggesting that its share price is 80% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ARQ
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
BioLargo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

BioLargo received 111 more outperform votes than ARQ when rated by MarketBeat users. Likewise, 60.99% of users gave BioLargo an outperform vote while only 0.00% of users gave ARQ an outperform vote.

CompanyUnderperformOutperform
ARQOutperform Votes
No Votes
Underperform Votes
1
100.00%
BioLargoOutperform Votes
111
60.99%
Underperform Votes
71
39.01%

18.5% of ARQ shares are held by institutional investors. Comparatively, 0.0% of BioLargo shares are held by institutional investors. 26.9% of ARQ shares are held by insiders. Comparatively, 20.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, ARQ and ARQ both had 1 articles in the media. BioLargo's average media sentiment score of 0.29 beat ARQ's score of 0.00 indicating that BioLargo is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ARQ
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioLargo
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

ARQ has a net margin of -4.07% compared to BioLargo's net margin of -16.53%. ARQ's return on equity of -2.38% beat BioLargo's return on equity.

Company Net Margins Return on Equity Return on Assets
ARQ-4.07% -2.38% -1.81%
BioLargo -16.53%-58.35%-32.12%

Summary

ARQ and BioLargo tied by winning 7 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLGO vs. The Competition

MetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ Exchange
Market Cap$63.80M$3.92B$9.11B$8.40B
Dividend YieldN/A2.75%1.81%4.16%
P/E Ratio-10.6019.6726.7716.67
Price / Sales5.2236.793.1576.46
Price / CashN/A10.8320.3133.53
Price / Book21.203.545.205.18
Net Income-$3.50M$244.61M$505.27M$223.67M
7 Day Performance-8.46%1.12%5.34%2.59%
1 Month Performance-11.63%-2.10%5.90%8.66%
1 Year Performance30.06%20.36%54.79%28.23%

BioLargo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLGO
BioLargo
N/A$0.21
-4.5%
N/A+34.6%$63.80M$12.23M-10.6030Gap Down
ARQ
ARQ
0.483 of 5 stars
$6.01
+0.7%
N/AN/A$219.45M$105.08M-50.08140Upcoming Earnings
ORGN
Origin Materials
2.7858 of 5 stars
$1.39
-0.4%
$3.00
+116.6%
+17.1%$203.63M$34.06M-15.39160Positive News
ALTO
Alto Ingredients
2.5533 of 5 stars
$1.78
+3.5%
$5.50
+209.0%
-58.9%$136.16M$1.07B-3.36420Upcoming Earnings
VGAS
Verde Clean Fuels
N/A$4.13
+1.0%
N/A+5.0%$132.37MN/A-8.102Upcoming Earnings
AMTX
Aemetis
1.4345 of 5 stars
$2.70
-0.4%
$12.95
+379.6%
-45.4%$119.88M$278.65M-2.35160Gap Down
TLGY
TLGY Acquisition
N/A$11.58
flat
N/A+4.9%$109.63MN/A0.003Positive News
EVGN
Evogene
1.8798 of 5 stars
$2.59
+7.9%
$12.00
+363.3%
-61.4%$106.75M$9.45M-0.65140Analyst Forecast
Gap Up
High Trading Volume
CBUS
Cibus
3.5593 of 5 stars
$4.07
-2.2%
$22.83
+461.0%
-61.2%$87.69M$2.96M-0.25183Upcoming Earnings
SDST
Stardust Power
1.1512 of 5 stars
$7.65
+2.0%
$12.00
+56.9%
N/A$71.11MN/A0.00N/APositive News
LOOP
Loop Industries
0.3337 of 5 stars
$1.39
-2.1%
N/A-60.3%$66.11M$101,000.00-3.4890Negative News
Gap Down

Related Companies and Tools


This page (NASDAQ:BLGO) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners